<SEC-DOCUMENT>0001193125-15-159084.txt : 20150430
<SEC-HEADER>0001193125-15-159084.hdr.sgml : 20150430
<ACCEPTANCE-DATETIME>20150430080241
ACCESSION NUMBER:		0001193125-15-159084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150430
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150430
DATE AS OF CHANGE:		20150430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		15815312

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d918941d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the&nbsp;Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): April&nbsp;30, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Florida</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-12111</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>26-3667538</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of&nbsp;Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File&nbsp;Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1301 Concord Terrace </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sunrise, Florida 33323 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) (zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code (954)&nbsp;384-0175 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Results of Operations and Financial Condition. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;30, 2015, MEDNAX, Inc., a Florida
corporation (the &#147;Company&#148;), issued a press release announcing the results of its operations for the three months ended March&nbsp;31, 2015 (the &#147;First Quarter Release&#148;).&nbsp;A copy of the First Quarter Release is attached
hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.&nbsp;The information contained in this Item&nbsp;2.02, including Exhibit 99.1, shall not be deemed &#147;filed&#148; with the Securities and Exchange Commission
nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits.</B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">99.1&#151;Press Release of MEDNAX, Inc. dated April&nbsp;30, 2015. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>MEDNAX, INC.</B></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: April 30, 2015</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vivian Lopez-Blanco</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vivian Lopez-Blanco</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial
Officer</P></TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release of MEDNAX, Inc. dated April 30, 2015.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d918941dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g918941snap1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR MORE INFORMATION: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles Lynch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Strategy and Investor Relations
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">954-384-0175, x-5692 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>charles_lynch@mednax.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>FOR IMMEDIATE RELEASE</U> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX Reports
2015 First Quarter EPS Growth of 14% to $0.72 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Expects Second Quarter EPS of $0.85 to $0.89 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FORT LAUDERDALE, Fla., April&nbsp;30, 2015 &#150; MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal, anesthesia, maternal-fetal,
pediatric cardiology and other pediatric physician services, today reported earnings of $0.72 per diluted share for the three months ended March&nbsp;31, 2015, an increase of 14% over the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the 2015 first quarter compared to the prior year period, MEDNAX reported: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Revenue growth of 12.9 percent to $639 million; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Operating income growth of 10.3 percent to $115 million; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Earnings per share growth of 14.3 percent to $0.72. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Our first-quarter results reflect a
continuation of strong operational and strategic growth as well as utilization of our capital,&#148; said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. &#147;Our revenue growth was nearly 13 percent despite the decline in Medicaid parity
revenue compared to 2014, and our earnings per share growth of 14% was favorably impacted by our share repurchase programs. We completed three acquisitions during the quarter, and our pipeline remains strong across all of our clinical specialties.
Our outlook for 2015 remains very positive, and we believe we are well positioned, financially and operationally, to bring value to our physicians, hospital partners and shareholders through our service offerings and our investments in clinical
research, education and quality.&#148; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operating Results </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX&#146;s net revenue for the three months ended March&nbsp;31, 2015 increased by 12.9 percent, to $639.4 million, from<BR> $566.3 million
for the prior-year period, driven by a mix of contributions from acquisitions completed since January 2014 and same-unit growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX&#146;s revenue growth attributable to recent acquisitions was 11.1 percent, while overall same-unit revenue grew by<BR> 1.8 percent
when compared to the prior year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Same-unit growth attributable to patient volume was 2.2 percent for the 2015 first quarter as
compared to the prior-year period. Volume growth in the Company&#146;s neonatology and other pediatric services, anesthesia and maternal-fetal medicine was partially offset by a decline in pediatric cardiology services. For the 2015 first quarter,
compared to the 2014 period, same-unit neonatal intensive care unit (NICU) patient days were up 1.5 percent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Same-unit growth from net
reimbursement-related factors was negative 0.4 percent. Same unit growth was reduced 1.5 percent due to lower parity revenue compared to a year ago. MEDNAX&#146;s first quarter 2015 results include approximately $6 million in parity revenue that
contributed approximately $0.02 to its net income per diluted share, reflecting the impacts of incentive compensation expense and income taxes, compared to $14 million and $0.04, respectively, in the first quarter of 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Excluding the impact of parity revenue in both periods, a non-GAAP measure, net same-unit growth from reimbursement-related factors would have
been 1.1 percent in the first quarter of 2015, and total same-unit revenue growth would have been<BR> 3.3 percent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On a same-unit basis,
the percentage of services reimbursed under government programs was unchanged in the 2015 first quarter compared with the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the 2015 first quarter, general and administrative expenses were $67.9 million, as compared to $58.4 million for the prior-year period, a
growth rate of 16.3 percent. General and administrative expenses as a percentage of net revenue was 10.6 percent for the first quarter of 2015, compared to 10.3 percent in the prior-year period, reflecting the mix of acquisitions completed over the
past year, including non-practice service businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense was $13.6 million in the first quarter of
2015 compared to $10.4 million in the first quarter of 2014, an increase of $3.2 million that primarily related to the amortization of intangible assets from recent acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operating income for the 2015 first quarter was $114.8 million, up 10.3 percent from $104.1 million for the prior-year period. Operating
margin was 18.0 percent for the 2015 first quarter, as compared to 18.4 percent for the prior-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX generated net income of
$68.7 million for the 2015 first quarter, or $0.72 per diluted share based on a weighted average 95.3&nbsp;million shares outstanding. This compares with net income of $63.7 million, or $0.63 per diluted share, for the 2014 first quarter, based on a
weighted average 100.7&nbsp;million shares outstanding, representing growth in diluted earnings per share of<BR> 14.3 percent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX had cash and cash equivalents of $50.2 million at March&nbsp;31, 2015, and net accounts
receivable were $360.9 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the first quarter of 2015, MEDNAX used $53.7 million to fund operations, which compares to $49.8
million used to fund operations in the 2014 first quarter. MEDNAX typically uses cash during the first quarter of each year as it pays incentive compensation, principally to physicians, and employee benefit plan matching contributions that had
accrued during the prior year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX used approximately $38.1 million during the 2015 first quarter to fund acquisitions and to make
contingent purchase price payments for previously completed acquisitions. During the first quarter of 2015, three physician group practices were acquired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also during the first quarter of 2015, MEDNAX used $233.6 million to fund repurchases of its common stock as part of an authorization by the
Company&#146;s Board of Directors to repurchase up to $600 million of the Company&#146;s common stock, announced on October&nbsp;30, 2014. These repurchases were effected through open market purchases and an accelerated share repurchase program,
announced on March&nbsp;12, 2015, and effectively completed the $600 million program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2015 Second Quarter Outlook </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the 2015 second quarter, MEDNAX expects earnings will be in a range of $0.85 to $0.89 per diluted share. This outlook assumes that total
same-unit revenue for the three months ended June&nbsp;30, 2015 will be flat to two percent higher, compared to the prior-year period, including an approximately two percent unfavorable impact from the decrease in parity revenue from the 2014 second
quarter. Excluding the impact of parity revenue in both periods, a non-GAAP measure, this outlook assumes same-unit revenue growth of two percent to four percent for the three months ended June&nbsp;30, 2015, compared to the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Included in the outlook for the 2015 second quarter is approximately $0.01 per diluted share from Medicaid parity revenue, reflecting the
impacts from incentive compensation expense and income taxes, compared to $0.05 per share in the 2014 second quarter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earnings conference call </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc., will host an investor conference call to discuss the quarterly results at 10 a.m., E.D.T. today. The conference call Webcast may
be accessed from the Company&#146;s Website, <U>www.mednax.com</U>. A telephone replay of the conference call will be available from noon Eastern Time today through midnight E.D.T. May&nbsp;14, 2015 by dialing 800.475.6701, access Code 356842. The
replay will also be available at <U>www.mednax.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ABOUT MEDNAX </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc. is a national medical group comprised of the nation&#146;s leading providers of neonatal, anesthesia, maternal-fetal and pediatric physician
subspecialty services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and includes neonatal physicians who provide services at more than 370 neonatal intensive care
units, and collaborate with affiliated maternal-fetal medicine, pediatric cardiology, pediatric critical care and other physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation&#146;s largest provider of newborn
hearing screens. American Anesthesiology, a division of MEDNAX, was established in 2007 and includes more than 2,400 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other
procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,675 physicians in 34 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to medical
providers in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at <U>www.mednax.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and information in
this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities,
events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as &#147;believe&#148;, &#147;hope&#148;, &#147;may&#148;,
&#147;anticipate&#148;, &#147;should&#148;, &#147;intend&#148;, &#147;plan&#148;, &#147;will&#148;, &#147;expect&#148;, &#147;estimate&#148;, &#147;project&#148;, &#147;positioned&#148;, &#147;strategy&#148; and similar expressions, and are based on
assumptions and assessments made by MEDNAX&#146;s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any
forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements
are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in
MEDNAX&#146;s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled &#147;Risk Factors&#148;, as well MEDNAX&#146;s current reports on Form 8-K, filed with the Securities and Exchange
Commission. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Income </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except per share data) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">639,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">566,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Practice salaries and benefits</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">419,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">372,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Practice supplies and other operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">524,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income from operations</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,097</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment income</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,371</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity in earnings of unconsolidated affiliate</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-operating (expenses) income</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,304</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income before income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax provision</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to noncontrolling interests</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to MEDNAX, Inc.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to MEDNAX, Inc. common and common equivalent share (diluted)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares used in computing net income attributable to MEDNAX, Inc. per common and common equivalent share
(diluted)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="8" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Balance Sheet Highlights</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited)</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill, other assets, property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,168,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,141,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,646,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,608,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and equity:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">212,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">380,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">897,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">569,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">422,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,532,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,343,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total equity</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,114,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,265,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and equity</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,646,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,608,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g918941snap1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g918941snap1.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`&T`R0,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\J0"@`H`*`"@`H`*`"@`H`*`/)OBM\0KSP%I^F?V99VUU
MJ&J7$Z1->"4VMO!:)&TSLD+HTDC--$JC>H'S$YP`?/S#&2P<*?LXJ4YMVYMD
ME:^BMKJD=N#PL<3*7-)QC!*Z6^NV^VQTGP_\6_\`":>&;36WMEM+EI)[2\MX
MV9H4NK5]LA@9OF\EU*.H;D;]I)*Y.^#Q'UFA&KR\KNXR72Z[>7Y&6)H_5ZKI
MWYDK-/K9]_-':UTG.07$CPV\\L<9EDAAED2(<&1XT9EC'NS`#\:3?*FTKN*;
M2]%L-+5+976I\`:1KGBG7?'>F:C#>WTVOW>LP!"DLH,,1N5,UJ(@<16$5N)%
M>+`01HVX=:^0I5<15Q=.:E)UI35M=M=5Y12T:VL?2SIT:6'G#E4:48O\M'YM
MOKO<_0:OL#YD*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`*]U=
M6UC;3WEW-';6MI#)/<3RL$CAAB4O)(['HJJI-*4HPBY2?+&*NV]DE_D.*<FH
MQ5V]$O/H?)?Q&^*?@WQA`ND_\(_JM_;V=R9K/5TOH-+N(Y,>7(]M#);7!:"1
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MMEB6/+$FO!6,Q$)NI"483ENXP@O_`&T];ZM1<%3<7*,=DY2=OQ/:_A[\<KRZ
MU"VT;QD+8I=R)!:ZW!&MKY4[D)%'J$"GRQ$[$*)HP@4D;UVDLOJ8/-92G&EB
M;6EHII6L]ES):6\U:W4X,3E\8Q=2A=<NK@]=%_*][^7W'U!7N[?(\@*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`\=^.-W<0>"#8VF]I]:UC3-*6
M*/[\PD>2X,*@==[6R+CONP>M>;FLG'"<D=ZLXPM^-OP1W9?%?6.9[4HRE?MT
M_"Y\K>-?`NJ>!;G3+74Y[:XDU*P%XIM=^VWD1_+GM'+_`'VC8K^\7Y6#`@#%
M>!BL)4P;IQJ-2<X\VG3HU\NY[&'Q$,0I."<5"5M?P?E?L4M!;4-#%AXTL6++
MHNOVEO<(@(:(O#]HB$I'_+&[ACO(.>,QD<[A4T>>CR8F'_+JHDUVTNOE)*2^
M1511J<U"7VX-KY.S^<=&?H=8WEOJ%E:7]JXDMKRVANK=Q@AH9XUEC;C_`&6%
M?8PDIQC..L9)->C5T?,RBX2<7HXMIKTT/C_QO:Q>-OC!=Z9$[M8V4*6M]/$V
M/L]MI-A)<ZA+OP0GESL\?/\`'A>IKYS%16*S&5-?#!<LFNBA%N3^3T]3V\.W
MA\#&6TF[I><G:/X69X1T''IQVSCIQ7D_H>CM\CW/QQ\.M*MO!'A_QKX7C=;9
MM,TTZW;B628%KF&)3J*&1F,4BWC&*9%(4%U9578V?5Q6"IPPM'%8>ZBXQYU=
MO=)<WE[VC6WH>=A\5-XBIAZNZE+D>VS^'[M4?3'PYU>;7/!'AS4;AB]S)IZ0
M7#GEGFLG>SDD8]V<P;B?5C7N8*HZN%H3>_+9^L?=_0\K%05+$58)62E=+R>J
M^ZYVU=1SA0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`&5KE]<:7HNJZE:6IO
M+FPTZ\N[>T&1]HEMX'E2+Y?FPS*`=O..G-9U9NE2J3C'FE"+DH]VE=(NG%2J
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MJL0N-'\5Z=/8W4#$KBZLD>]LKB)AS'<1F.8(XY4R`]JG+7&59X>HN:E7BXM>
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M3\/[`>&?`.@6VI2Q6OV33/M=[+/(D45N;IY+V0RR.0L803X))`&TUZ>#A]7P
M=&,VH\L>:3>B5_>U?2US@Q,O:XFHX*]Y627EHK+Y'6Z;JFFZQ:K?:5?6NH6;
M,Z+<6<T<\)>,[73?&Q`=3U4\C(]:Z(5(5(J5.:G'O%W6AA*$Z;Y9Q<6NC5B_
M5DA0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`>+_$[XCZIX:>31O"VGF_UB"Q_
MM/5;PVTMU:Z%IQ)6.:XCCPOFOM9AYK*BH`Q#;@!YF.QM3#_NL/#FJ1CS3E:Z
MIQZ-I=7YZ)'?A,+"K:=:7+3ORQ5[.;[)OHO(^;/#&I^)O$WB.#1+/6ET%O$M
MWY>HW.DV=II8D14EGE+C3X86D/EK+MC#JK.XSU)KQ*$Z]>LJ4*OL?;NTG!*'
MF_A2OULNYZM6%*C2=25/VBHKW5)N7DM[_>?5^I^']9\,^"T\._#FRA:]8/`;
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MOJ]OD?.GS=^T5J#KIWAK18LLUW?W-Z\2\E_LD*6\`VCJ3)>-@>HKQ,YFU"A2
M7VI.5O167YGJY7'WJL]N5)+YZO\`([GPA\+?#^E>$5T?5=,M;O4-4LPVM74T
M,;W`N)X\F&WF92UNMJ6"1F,K\T?F?>8UUX;`4:>&5*I34IS7OMK6[Z)].7I;
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M0@M%"/\`-)[M[VVU\D?2M>W^!Y.WR"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`\,^+6MZ/X2\.:WIUF5;Q#XSD99$#"2\>&18[6:YFP-RVL5G&+6!.!N8!02
M)#7E9C5IX:A5IQ_C8IZKK;9M]4DERQ7W=3T,%3G6JTY/2EA]NBONDO-O5_\`
M#'S9INE>(O!'B/PIJNL:3>:6C:G875JUR@19X5N(5GCRK'9(()3NB?:X#C*\
MUXD*=;"5L/4J4Y4_>BXW72ZOZ.SV>J/6E.E7I5H0FI6BT[='9V_%;K0_0:OL
M-O(^9/GKX5:/CX@_$W6)%YM-8O-,@8CH;K4;F[G*GL?+@ML^S^]>/E]*V,QU
M2UN6<H+YR;?X)'IXR?\`LV$IKK%2:](I+\V:/@_238?&3XAR*NV)]-LKH8&!
MNU5[6Z;_`,BPS_K5X:G[/,\9;1<J?_@;3_S)KSYL#A5U4FO_``&Z_P`CW2O5
M/./!?%6D_P#"3?&7PK8.F^R\/:(NMWJD90%+V=X$8=,/=)9#!Z@-Z5Y.(I^W
MS/#PM[E"'/+Y2;7WM)'I49^QP%:2TE4ER1^Y)_<KGO5>L>;M\CYZU7039_'K
MPYJ$2;8M7TVZOW*C"BXL=-N[*X_'8MJQ]Y/>O'J4N3-Z$TK*I%R^<8N+_)'I
MPJ7RVK#K3DH_)R37ZF-\<H-7\2>)?#/A31;.6^NH=.O-4^SP[5YN)?(,DCR,
MJ1QQQ6;?,S`9EQU8"LLUC4K5Z&&I1<I1BY67F[==%9+?S-,O<*-&K6J248\R
MC=^2O^OX'5_`W5XH]"O/"%ZAL=>\/:A>"YTZX'E7/V>XF,HF$;8+!)GDC8C.
M,(<XD7/1E-1*C+#27)5H2=XO1V;WMY/1]M.YCF$'[2-:/O4ZB5I+:ZTW_%?\
M`]SKU3S@H`*`"@`H`*`"@`H`Y>3QOX+@DDAE\7^%X9H)'AEBDU_28Y(98V*2
M121M=AHY%=2K*0"""",BK]G4_DEY:,CVE-:>TBK=.9?YFAIGB#0=::6/1M;T
MC5GMU1ITTS4K*_:!7)6-I5M9I#$K%6`+8!VG'2DX2A;FBX]KJPXRC+X9*5NS
M3_(V*DHIWVH6&EVTE[J=]9Z=9Q%!+=WUS#:6T9D=8XQ)/<.B(6=E4989+`#D
MTTFW9*[[(3:BKMJ*75Z&!_PG?@?_`*'+PI_X46D?_)E5[*I_S[E]S)]K3_Y^
M1_\``E_F'_"=^!_^AR\*?^%%I'_R91[*I_S[E]S#VM/_`)^1_P#`E_F-;QUX
M'*LG_":>%DRI7<OB+1PR9&-RDW9`8=1D'I1[*I_))?)_Y`JM-?\`+R.G]Y?Y
MG":?8_!VQUAM?E\4^'M6UHR"9=1UKQ?I^IS12+]QX4GOO*B*?P;8QLP-FVN2
M&6TX5/:NE.I5WYI\TVO2^BMTTTZ'3+'R=/V2JPA36G+#EBOPU]>X>/\`4O!7
MBRQT33X_%WA(BV\2:7?W%P?$>B@VMC;><UXZ[KW+-)%^Y"KG+3(3P"08S!U<
M1"E!4I>[5C)OE?NQ5^;[UIZV#"XJE0E4E[6*_=R27,M6[)=>F_R/1+?QCX0N
MY!#:>*O#=S*Q`6*WUS3)I"3P`$BNB2?H*ZW3FOL25O)G.JE/93B[=$T1^'-"
M&C7'B6Y^0_V[X@GU=&0ALPS6=E$@)'<2Q3''^UGO7+1H^QE7?_/VHYKTLDOQ
MN=%6ISQHK_GW!1^YO]+"/;:9H&K:YXHU*_L=/MM1M-&LY;F^N8;2"$V#7L:>
M9<7#I&OF-=QJHW<E0.N*N%&U:I4BKNI&"LEK[E_\_P`")U4J5.#?*J;D[MV7
MO6_R$7QUX)9E5?&/A5F8A55?$.D%BS'"JH%YDDD@`"M_95%_R[DK>3,?:T_^
M?D?_``)?YEVTT*WM->UC7]_F7>J6VG60!0#[-::<DNV)&R=WF3SR2,<#H@_A
MR>>-%0K5*OVIJ,?10Z?-N_W&[J-TZ=+:,')_-_Y)6->>X@M();FZGAMK:WC>
M:>XN)$A@@BC4M)+-+(P6*-5!)9B``"2:V2>B2UZ(S;279(X"[\1?#^[UK1]:
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M,RLRQ++=2(K2E4<A0<X1CC`-*,9/2*;MT2&Y1BO>:BO-V_,Q?^$[\#C_`)G+
MPH,?]3%I`QC_`+?*KV53_GW+[F3[6G_S\C_X$O\`,Z6WN+>[@ANK6>&YMIXT
MFM[BWE2:":&10T<L,L;%)(V0@JRD@@@@XJ6G'2UFNA::LK;="*]O['3+66]U
M&\M-/LH-IFN[VXAM+6$.ZQIYL\[HD>YV51N89+`#DT)-NR5WV0-J*NVHI=7H
M<_\`\)WX'_Z'+PI_X46D?_)E5[*I_P`^Y?<R/:T_^?D?_`E_F:`\2^'"NGN-
M?T0IJS%-)<:K8E=3=91`RZ>PGQ>,)B(R(=Y#D+U.*7)-7]U^[OH]/7L/GAI[
MR][;5:]-._R-NI*/YC/B)!#_`,+%^(G[F(_\5[XR/,:'G_A(M1]J^KI:4Z72
MT(_^DH^.JJU6K_CG_P"E,[KX`?%R^^!WQ)T?QC9+(VD.PTOQ7ID'R_VGX<NI
M8_MB",8#W=JRI=VY/26V5?NR,#GB**KTI4WNM8OLUM\GL_(UPM=X6M&:^':2
M[QZ_-;KS1_11I&K:;KVE:=K>CW<-_I6K65KJ.FWMNV^"ZLKN%)[:>)O[KQ.I
MYP1G!`(Q7S,HN#<6N5Q=FO-:'U<9*48RB[QDDT_+H?C]^WK\=!XO\41_"'P[
M=B7PWX-NQ<>*)87W0ZKXL1"J6#$'$MOI,4C(PZ?:YY@1FU0CV\NP_LX>VDK2
MFO=\H]_G^7J>#F>)YYK#P?N4W[WG+M_V[^?H?G=Y$'_/&+_OVG^%>F>38C9;
M2,X9;=3UPRQ@X[<$4:AHO(;_`*%Z6WY1?X4:AIY#UCM7SL2!MO7:D9QZ=![4
M:KRL&@XPVZC)BA4#N40`8]\4!MY6$1;8,#$(0Z_=,>P,,=,%.11JOD&GW'L_
MPX^/?Q;^%-Y!/X0\::O%91.K2Z!JMS-K/AVZ1>#%-I5](Z0@J2/,M6MY5SE7
M!K"IAZ-56G35ULUH_O7ZW.BCBJ]!KV=1I+[+UC]S_2Q]W_%/]HK0OVA?V3?'
MICL%TCQGX=N_"$OBGPTK-<Q0V[>)--1-<TN1AOGT224%2[C?;28BF/,<DWGT
M<++"XRGKS0DI<K_[=>C[-?CT\O3K8N.*P-73EJ0Y>:/_`&\M5Y?ELS\J_(A'
M_+&(8Z8101CH00."/:O6V^1XEOP/V>_8F_:5_P"$_P!&A^%7C6_W^-O#ME_Q
M3^I74F9?%/A^T0`122.<S:UIT*A9>2T]NJ3X+13M7AX_"^R?M::M3D]4OLO_
M`"?3L].Q]#EV,]K'V%1_O(+W7_-%?K'KW6O<^J_CR`?@I\6`0"#\/?%@((R"
M/[$O."*Y,-IB*/2TX_FCNQ/^[U_\$O\`TEG\V@@@"C]S$,+_`,\T&,#Z5]0?
M(6MY6/WB\'_$2T^$_P"QEX2\<3>6)=%^&6DC2;=MH6ZUN[MULM%M`A^\KZC/
M;[P.D:R-T4U\].DZV.G376;OZ)W?X'TU.JL/E].IMRTU9>>R7WGX47DTNH7E
MWJ%^_P!KO[^ZN+V]NI@'EN;NZE>>YGD=AEI))I'<D]V-?0)<J26BCHEY+8^:
M>K;>[U;\S[:_8+^)R^!OBX?!M[,L&A?$FU32@A.R&'Q+IXEN="FVCCS)T:]L
M1_>>\A'\(QP9A2YZ/.OBI:_]NO1_=H_D>CE=;V5?V;=H55;_`+>6L?OU7W'Z
M_?%+X:^'?BUX&UWP)XF@633]8M2L%R(TDN-*U*']YIVK61<?)=VMRJ2+@C<H
M>-LI(P/BT:LJ%2-2&CCT\NJ?J>]6HPKTI4IK22^YK9KS3/YSO'_P_P!9^&OC
M'7O`_B>QBM]8\/WKVLS+"!!>6Y`DLM2LV91YEE=VC13Q-_=EP<,K`?34ZD:L
M(U(/W9+[NZ]5L?)U:4J-25*:M*#M\NC7DUJ?IM^P#\=_MME+\#_$UY_I6F17
M&I>`9YW^:XTQ"T^I^'%9CS)9LSW=LG7R)+A!A;5!7E9CA[-5X+1Z37GT?SV?
MG;N>QE>)NOJTW9QUAZ=8_+=>5^QYG^WM\=QXJ\0I\&_#=V'\/>%+I+GQ?-"V
M8M4\3QC]QI3$$B2VTE&)D7H;N9@1NLU-:Y=A_9Q]M)6E)>[Y1[_/\O4QS/$\
M\_J\'[E-^]YRZ+TC^?H?)OP#^"E_\;_B+I?@^RA-MH\)74_%>KQ0J1I/A^WE
M1;ET?;M%]<L5M;93UEF#D;(G([<176'I.;WVBN[_`,ENSAPN'>)JQIK2*UD^
MT5O\WLC]@O'/[/\`J%QJ.G6G@JST:W\-6OA_2O#NEV-Q=26-MX<MM,MWT];>
MZMHX'?4='6WGGU")+62&X.IL9)BR.77Q:>)23]HWS7;;[WU^3TL[Z<NQ[]3"
MNZ5-)0C%12V4;:;=5U5M>8]T_P"$&U/_`*'CQ+_W\B_PKF]JOY(_<=/LW_S\
MD?SK?$3_`)*+\0_^Q]\8_P#J1:C7TU/^'3_P1_\`24?)UOXM7_'/_P!*9Q_3
MV_3I_A5F9]O_``5_;!U?X6?!;QC\/9EN;SQ!9PLOPMOF0S0:4=7E>/4K>^9F
MQ';:;)))J-JI#!WD>W.$"XX*^"C5KTZFT?\`EXO3:WKL^VYZ6&Q\J&'J4MY1
M_AOM?>_^'=?<?$DTT]S--<7$LMQ<W,TMQ<3S.TD]Q<3.TL\\SMEI)7D9W9CD
MDDDUWI622T2V1YWYD=`C]-OV2?C9^S[X`^$QT#XFZIH=GXE'BC6[X0ZAX5O]
M7N/[.N5LA9M]LMM&N4V$Q383S<K@Y49&?*QE#$U*UZ2?(HI:22U5[Z-H]G`8
MG"T:')6DHSYF[.+>FEM4F?3G_#47['7_`$'O"W_A`ZM_\S5<GU3&_P`LO_`E
M_P#)';]=P'\\?_`'_P#(GQM^V_XH^'?C?P[\'?%?PS.ES^'[^Z\>V?V_3=&;
M1OM-SIDGAV">*6&:QM9W\F1F"ETV_.Q0_,2>[`0J4Y5H5;J4>31N^_-YM'G9
ME.E4AAYT;.#<U=*VW+W2>A\R_LUZ?8:K\>?A9INJ6-IJ6G7?BF&&[L+^VAO+
M*ZB-G>,8KFUN$>.:/<JG:ZL,J..*Z\2W'#UG%\K4=&M'NCCP:3Q5!-)IRU3V
MV?0_=K6/@9\&=>LY+#5/A;X#GMI5*L(O"^D64R@\$Q75C:PSP/Z-'(C#L:^>
MCB*\'I5FK?WG^K/II8;#R5G1A;_"E^231^0/[7_[-FG?`W7-&UWP?)=/X%\6
M2W5O:V5Y*]S<>']9M46>73/M<F7N;":V9I;9Y2TJ^1/&[/Y:N_M8+%/$1<9Z
M5(6N]KK:]NZZ_(\''X-86494[^RGLG]EKI?MV^X\,^"'B2W\-?$WPS_:2"?P
MYXCN_P#A"O%]@_,&H^%?%Q71-7MID/#>7'=)=1$_<GLX9%(9`1T5X.5*5M)0
M]Z+[2CJORMZ'+AIJG6A?X)/DDN\9>Z_SNO-(XWQIX:G\%^,/%7A"Y8O/X7\1
M:QH+R'K+_95_/9I-_P!M(X4?_@=:4Y<\(36BE%/[U?\``SJ0]E4G3_Y]R<?N
M=C-T+7-6\,ZSI?B'0+^?2]:T6]M]1TO4;5]D]I>6SB2*5#T9<C:R-E71F1@5
M8@N45*+A)7BU9H492IRC*#Y91=T^S1^UFC_'G2/CM^RS\4-77R++Q;HWP\\2
MZ?XQT-&`-GJ1T&]\O4+1"=S:3?+&\T#'.PB6!B7@8GPGAWAL716\)3BXORYE
MIZKK]_4^BAB8XG!5I?#.,)*4>SY7JO)]/NZ'X>C[H^G]*]X^;/LW]H#XGFX^
M"O[/'PBTZXS#IG@+0O%_B9(WRIO;JTEM/#]E,HZ/#:&^NBISQ>VS=0*XL-2M
M7Q-9JUYN,?1.[_1?)GHXJM_L^$P\7I&$92];6BODKOYH^?\`X9_"SQ+\5+KQ
M39^&X@TGA3P;K?C"\W(SB:+2(E:#38=O_+[>SN(81W(8X(4UT5:L*"AS:<TE
M%?/KZ+J<E&A.LYJ'_+N#D_ELO5]#S_3=1O-)O]/U;3+A[34-,O+34M/NHR4D
MMKRRGCNK2=",$,D\4;?A6C2:<6M&K->6QE%N+4HOE<6FGYK5'])GPC^(%E\4
MOAOX1\=V)11KVD03WL"$$6>K6^ZTU>Q(!.WR-2@NHQG!*HK=&%?+UJ3H59T_
MY7IZ;K\+'U]"JJU&G46G,E==GLU\F?+'[;W[/_\`PLCP>/B)X7L?,\;^"+*5
M[J"WC)N/$'A6,O<7ECM09FOK`F6[MAU93=0C+2QA>S+\3[*?LI.U.;T_NRZ>
MB>S^78XLQPOMJ?M8+]Y26W>/5>JW7S74_&+0]<U;PWJ^F>(-`U"YTK6='NX;
M_2]2LW\NYL[N`[HIXF((R.058%65F5@58@^Y**E%QDKQ>C3['ST92IR4H/EE
M%W371HACCU'6M2CAA2[U35]8OUCBC0/<WVI:GJ-R%55'+SW=Q=S`=RSR>IHT
M@OY8Q7R27^0DG)V5W*3^;;_5L_?_`/9?^!5I\#?AU:Z;=QP2>,_$'D:OXROX
M]K_Z>T6+?1[>4#YK#387:%,$AY6N)A_K\#YS%XAUZEUI"&D5Y=_5[_<NA]3@
ML,L+14?^7DM9OSZ+TCM][ZGTE7*=84`?S(_$3_DHOQ#_`.Q]\8_^I%J-?5T_
MX=/_``1_])1\=6_BU?\`'/\`]*9]7_`SX$Q?&W]G7XEQ:7;Q#QSX4\:)J_A*
MX*JLMXZ^';,WWAV67_GVU"&,*@/RI<Q6\A(4/NY,1B/J^)I7_ARC:2[:NS]5
M^6AW87#?6,)5Y5:I3G>#_P"W5>/H_P`['Q'+%+;RRP3Q203P2R03P3(T<T$\
M+M'+#-&P#1RI(K(RD`@J0>17<O+;H>=:VFUNGH?<WP<^`AL_V>/B]\<?%%D!
M<7O@3Q#IWP_M;F+)@LFB,&I>)U1Q\LMP5DM+1^HA6YE'$\;#@K8C_::&'@_A
MG%S_`$C\MWYV['I8?"\N$KXF:U<)*"\NLOGLO*_<^%1T%=YYAZUX*^!/Q>^(
MFB_\)%X(\"ZKXAT07EQ8?VC9SZ9%#]LM!&;B#;=WT,F]/-CR=F/FX)K*=>C2
MERU*BC*U[:[=-D;T\+B*L>>E2<HWM=-;KU:.N_X9-_:-_P"B3Z__`.!>A?\`
MRVK/ZWAO^?R^Y_Y&GU'%_P#/A_?'_,Z3XT^"?%7P^^"'P)\,^,]%N?#^O6_B
M#XLW<VF7;VTD\=M>W_AN6UE+6DTL>V2/Y@`Y/J!4T)PG7Q$J<N:-J:37DG?[
MB\13G1PV%A4CRR4JCMI_=ML<=^RY_P`G#?"3_L;8/_2&^J\7_NU;_#^J,\%_
MO=#_`!?HS^B2OF3ZL_.3_@H]K^F6_P`._`OAAY(FUC4_&#:S;P;E,\6G:/I%
M_:7<Y0'*0M<:M9QAB`&8$#[IQZF5Q?M*D_LQC;YMJWY,\G-Y)4:5/[3G=+R2
M:?YH_*#P9I]SJOC'PCI=E&TEWJ'BCP_8VL:`EFGN=7LX8PH'.=SCIZ5[$VHP
MF]E&+?W)GATTW4IQ6[E%+[T=S\>M0MM4^./Q5O[)TDM9_B#XC$$B8*2K;ZI+
M:F12."KO`S>^ZL\.G'#T5U4(_D:XIIXFNUMSRM\G;]#WO]K?]FYOA?=Z;\1/
M!]B5^'_BJ.R-[9VZ,8O"?B&ZMTD>T(&?+TB^DWR6S'B*4R6YP#!OY\'BO:IT
MIO\`>0V?=+]5U\M>YU8[">P<:M-?NIVNOY)?Y/IVV['RCX3\:^(O!,^LR^'[
MYK5/$/AW5_"NN6K9>UU/1-:M)+6ZM;J'(#E"Z3PO]Z*:%'4]0W7.G&:CS+X)
M*4?)K;_)^1PTZDZ3ER.W-%QDNC35GI^*[,Y3&!CTX_*KV^1F6+BZN+MUENIY
M9Y$@M[9'E<NR6]I!';6L"D_=BBMXHXT4<!4`%"26RL-M_=9?=HON/TN_8K^)
MOP&^$'@;7[[QOX^T;2/&?B[5O]-TZXLM6N)[#0M)1[;2[222UTV6/,TTU_=,
MJR$%;B$,-R8'EXZEB*U2*ITW*G36CNMWONUY+Y'L9=6PV'I2=2JHU)O56>D5
MHEHO5_,^#OBS:>#[+XD>,$^'^L6FN^#)]:N=0\.W]DEQ'`-.U$B^2Q$=W!#*
MK64D\EH=T:@_9@1D$&O0HN?LH>TCRS2M)>:TOIWW/,KJG&M4]E)2IWO%KL];
M:VVV^1^@?_!.CXH>5-XK^$.I7&%E#>,/"Z2/@"11#9^(;&$'N5^P7:H/[MT_
MK7FYG1TA62V]V7YQ?YK[CU,IK6Y\.W_>C^4E^3^\_1;XH_$?P_\`"?P-KWCG
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ML`RD#YB494Y.$ERN+LUZ'UL)1G&,H.\9)-/R-FI*"@#^9'XB?\E%^(?_`&/O
MC'_U(M1KZNG_``Z?^"/_`*2CXZM_%J_XY_\`I3/U0_X)N?\`)//B)[>-;3\,
M:#9UY&::5*72T?U9[>4?P:O^/]$3_&C]BF/Q]\=?#WB_0_)T_P`#^*;N34/B
M;!#*D$]G>Z>$FGGTR+AFDUY0L#F,-Y-QY]RW$H%%#'^RP\H2UJ05J?ILK_X?
MQ6@8C+O:XF%2/NTY:U%V:[?XMO)W9],?M$:?8Z3^SC\3M+TRUAL=.TWX?:A8
MV%E;(([>TL[2T2"VMH(UX2*.&-$51T"BN3"MO%4FWJYIM_,[,4E'"5HQ7*HT
MVDNR2LON/YWQT%?2GRA]U?L[?MD:?\"?AX?`USX`U#Q++_;VJZU_:5KK]IID
M0745M56W^S3:=.VZ/[,<OOP=XX&.>#$X%XBIS^T4;)*UK[7\T>GA,P6%I>R=
M)RLV[J26]NENECW;_AY;HW_1']8_\*_3_P#Y2US_`-E/_G\O_`7_`)G3_;$?
M^?#_`/`E_D?)W[3O[2MG^T,?!IM/!]YX4_X13^V]_P!KU>WU7[;_`&O_`&;M
MV?9[*W\CRO[/.<[MWFC&-O/9A,*\+S^_S<UNEK6OYON<.,QBQ?L[4W#DON[[
MV[)6M8\+^&/C>3X:_$#PGX\BTY-7D\*ZJFJ)ICW)LTO"D$\(A:Z6*4P#]]G<
M(W^[C'-;U:?M*<Z=^7F5K_\``.:C4]A5IU4N;D=[;>6Y]XZK_P`%)O%LUI)'
MHGPN\/V%ZRE8[K4_$.H:E;PD@@.;2UT^S:8J<';YZ`XZUY\<K@G[U5M+HHI?
MFV>F\WJ6]VC&+[N3?X)+\SX,^(?Q'\8_%/Q+=>+?'&L2:OK%PBP1X1;>RT^R
MC9FAT_3+*/\`=V=E&SN0BY+,[/(SN[,?0I4H48J%./*E]]^[?<\RK6J5IN=2
M7-+\$ET2Z(]?^"OA76?"7AKQ-^TA?:3,^A_#R'[+X)-Q'LM]9^(.K3)HNCWT
M7F`"?2]!N+[^T)Y$R&N+:W@4D^;Y>->49RCA4[2J?%Y06K7K*UEY79OAJ<J<
M)XMQ]VC\'G-^ZGZ1O=^:2/FQI)9IS--(\LTTYFFED):26:23?+*['J[.S,3Z
MDUU;:;)=#DZG]--]X9T3QEX&/A;Q'80ZGH>N^'K?3]2L9URDUO-9Q`E3UBF1
MPLD<JX:.2-'0AD!'RJG*G4YX/EE%W3]#[%PC4I\DUS1E&S7R/P#_`&@/@CKG
MP)\>W?AF^\Z\T"^\W4/".O.FU-6T<R8$<S*`J:K9LRP740Q\VR51Y<\9/T>&
MKQKTU)>[*.DEV?\`D^G_``#Y?%8:6%JN#U@]8/NO\UU^_J>'5N<IK:%H.L^)
MM8T[P]X=TVZUC6]6N5L],TRS57N;RY=698H@[*H.U'8LS*JJI9B`":4I1IQ<
MI/EC'=OH5&,IR4()RE+1)'L__#+'[17_`$2+Q5^>D?\`RSK#ZWAE_P`OHZ>O
M^1T?4L7_`,^)?A_F<SXM^!7QB\!:+-XC\8_#SQ!X>T*VFM[>XU2]6R>U@FNI
M1!;)*;6\E:,23,L88J%W.H)!89J&(H3ER4ZBE+HE?IZI;$3PV(I1YJE*4(QM
MJ[6[+9LQ?A;X[O\`X8_$+PEXZT[>TOAW6+:[N($8K]LTR0FVU:P8@_=N=-FN
MH?K(#VJJM-5:4Z;^TK+R?1_)DT*KH5:=5?8=[>6S7S5T?0_[8'[1$?QI\7VN
MA^%KR1_ASX2.=)8"2%->UF>$+>Z[-"X#>5$CM:6JN,J@GD`!N2!S8+#?5X7D
MK5);^2Z+]7\NQUX_%_6*BA!_N:>WF^K^6R^;ZG/?LI?`!OCGX[ECUF*ZB\!>
M&(5O/%-W;N]N]W/<+(NEZ#:7*C,5U<R(\TC*<QP6LAX:2/-8O$?5Z?N_Q):1
M7:V[^7YD8'"_6:OO:4J>LNGI%/\`'T1Y?\9_A7K/P9^(>N^!M7\R:.RE^UZ'
MJ;1[(]9\/W;.VF:C'CY?,,:M#,BDB.XMYX_X1G:A6C6I1J1TOHUV:W7^7E8Q
MQ%"6&JRI2^SK%]X]'^C\TS[5_8*_:`_L'51\$_%5[MTC7+F:Z\"75Q)A-/UR
M8F6\\/;W/R6VH$//;+G`NA+&H+7BXX,PPW-'V\%K'XUY='\MGY>AZ.68KD?U
M:;M&7P/L^L?GNO/U/UVKQ=O*Q[H4`?C7XL_8%^-NM^+?%FMV>J>`5L];\3^(
M-8LUGUG5DG6TU35KN^MEG1="94F$,Z!E5F`8$`D#)]R&8T(PA&T[QC%/1;I)
M=_(^?GE>)E4G)2@E*4FM7LVVOLGVW^R%\#?&7P*\*>+-$\9W.AW-YK?B*#5;
M-M"N[J[@6VBTRWLV6=[JRMBDOFQ,0%5AMP<YXK@QN(AB)0=--**L[V[^39Z6
M`PU3"TYPJ.+<I77*V]+)=4CZYKB.X\T^,?A'5/'OPM\=^#-$DM(M6\2>'-0T
MG3Y+^62&R2ZN8]L;7,L44KQQ`]2L;D>AK:A-4JU.<K\L))NV^ACB*<JE"K3C
M92E%I7V/R7'_``3R^.H_YBOP\X_ZC>K]O^X!7L?VEAUTGIY+_P"2/#_LK$K[
M5/3S?_R(?\.\OCK_`-!7X>?^#O5__E!1_:6'_EG]R_\`D@_LK$_S4_OE_P#(
MA_P[R^.O_05^'G_@[U?_`.4%']I8?^6?W+_Y(/[*Q/\`-3^^7_R(?\.\OCK_
M`-!7X>?^#O5__E!1_:6'_EG]R_\`D@_LK$_S4_OE_P#(A_P[R^.O_05^'G_@
M[U?_`.4%']I8?^6?W+_Y(/[*Q/\`-3^^7_R):M/^"=GQLFE6.Z\1?#RQAS\T
M_P#:6N714#N(8M#0L?;<OU%#S.@EI&;MTLO\QK*<1UG3BO67^1]&_#/_`()V
M^#-"N[;4_B9XHN_&\L#)+_8&EVSZ%X?=T8-LO9A<2W^H0'!!19;0'HP(R#RU
M<SFTU2A[/S>K^71?B=='*:<&G6FZEOLKW8_/J_P/I3]H#X07_P`0/@CJ?PN^
M']MH.ARM)H":19W&[2]%LK/2=5M+QX$6QM)?(400.$5(2"Q&<9)KEPU=4JZJ
MU&Y6O=[O5-=6CLQ5!U<,Z%)1C\-ELDDT^BTV['YJK_P3S^.JLI_M7X>X5E/_
M`"&]7Z`@_P#0`]J]3^TL.ND_N7_R1X_]E8E?:IZ>;_\`D3]I=.@>TT^QM92O
MF6MG:P2%"2I>"!(W*D@$KN4XR!Q7A-ZOH?0Q7*DOY4CR;XZ_!GP_\<?`=_X1
MU@1VFHQ;K_PSKGE![C0M<BC9;>Z0CYGM)03#<P`XEAD8<.L;)MAZ\L/44X[;
M27=?UMYF&)P\<12=.7NM:Q?\KZ?+HUV/RR_X=Y?'4?\`,6^'AQW&MZP,X[X.
M@5Z_]I8=?9FK>2_^2/%_LK$_S4]/-_\`R)]+_LK_`+'?B_X2?$:;QW\0KOPU
M>G2]&NK3PU;Z'>7EZ\.J:B1;7=]<_:].MEB$6F_:(8]I<DWK'C8,\N+QL*U+
MV=)2C=KFO9:+9:-]?R.S`Y?4P]5U*KB^56BHMO5Z-ZI;+3YGZ.5Y9ZQP_P`2
M?!&G_$?P%XK\#:F%%KXET6\TT2L,_9;IX]^GWR@?\M+6_CMKA<?Q0"M*-1T:
MD*B^PT_\U]VAG5IJK2G2>BDFO\G\GJ?D)_P[R^.PX_M;X>''&1K6L#..^/[`
MXSZ5[7]I8=?9GIY+_P"2/!_LG$K[5/3S?_R(?\.\OCL.FJ_#P?\`<;U@?^X"
MC^TL/VG]R_\`D@_LK$K[5/3S?_R)^J?P,^$>D?!3X=:+X*TWRI[V%/MWB+54
M0HVL>(+M$.H7Q+`-Y"LB00(W*6]M"I^8$GR,16E7JN;T6T5V2V7^?G<]O#4(
MX:C&DMUK)]Y=7^B\DCS/]JO]G1?CSX3T\Z%)IVG>//#5SYF@ZEJ!DAM+K3[I
MXUU/1M1GMX995MG54N(F$<GESVZX`6:0UK@\5]6F^:[IRW2[K9K\O0QQN$^L
MTURVC5A\+>UNJ=NG5>:/S^M_^"?7Q]LYX+JTUSP%:W5I-%<VMS;Z_K,4]M<V
M\BRP7$$J:"&BFCE1'5@00R@CI7I?VEA]N6=NUE_F>4LJQ46K2@G';WI=-OLG
MZ[_#I/'$/@S0;;XCC2&\9VEDEIK=UH=S-=:9J-Q;9A34H&GM;=XI+J)(YI83
M$!'+)(J$H%KQ:OL_:2]E=4[Z)Z->6C>Q[U'VBIQ56WM(JSY=M.NRW.VK,T/G
M?P#\6-7U?3-0M?$B06VLR:;J>H^&]12V$%EJHL+5Y)K58PQ0WENZI(4!&]'/
M`*_-XV$S"I4A.-:T:G+*5.5K1ERJ[5MKQ>OFCOK86,)1=.[@G%35[N-WOZ/\
M#?N?'6O)\./"^HV7D77C3Q:EC9:5$L"+"^H7!9Y[DVQ.Q8(;>-V.3M4LFXX)
MK:6+JK!8><+2Q6(Y8P5E;F>[MM9)?D0J,%B*D7>-&E=O7HME?S9'<>*/%^M>
M!K?Q9X?U;3-(GT?3=4;Q-IU]I1O97U724Q<VT),J?8SYD$I`8-\MQ&3TH=?$
MU,)'$4:D:3I1E[6,H7?/#=+^7;\4"I4J=9TIQ<E)QY&G;W7MZ_\``*!\1_$'
M3/#'A_Q#J.N:/?#Q'J_A."U@MM&%LUG9ZNSO>PS,TS":4QM$BNH7:8V(SFH]
MOC*="C6G5A+V\Z2BE"UE/XD^^EE?R*]G0E4G3C"4?9QG>\NL=O0V(]8\?>,=
M0UR3PEJ.B^'M#T+4[G1;>;4=.?4[K6+^QVK=R./,46EDLC!5*@N0<\D$#15<
M7B9U?JTX4*5&3@G*/,YRCO\`X8]K:D<E"C&"JQE.<DI-)V44]O5G,:G\5?%5
MKI>ARP:5;MKMGXLU+PYXGT>WC,Z7SZ5:?:9O[,D+%X?-AS(A^<AE*X8=<)YA
M7C3I-4U[6-65.K!*ZER*[Y7TNM5N:1PU)RFN9J#@I0D]+7=E?T.YT_QR=<\7
M>%K71KJ&?P[KGA;4]7=3"OVE;VTNHH%B>3.Z"2$L\<D6/O*>>A/7#%>UQ%"-
M*2=&K2E.UM>9.UK]&MFC%T?9TJCFK5*<U%=K6_&_0QM)^(^I7GCV2QFBC7P5
MJ-]?>'-`U`1J#-X@TF.*6Z8S@Y>&=S/%$",%HUVDD/65/&SEBW!I+"RE*G3E
M;_EY!*^O9ZI%RP\8T$U_&BE*2_NO;3RW9U_A?7M2U3Q-X\TN\DB:ST#4M,MM
M-1(5C>.&ZT_[1,)9`<S,9>03C`XKIH59SKXNG)KEH2BH*UK)QN[OJ95(1A3H
MR2LY)W^3LO0?\2-=U+PUX-U?6='>*/4+3[$+=IX1/$#/?VMNX:)B`V8Y6`YX
M)![48VK.AAJE6E93CRVNKK626P8>$:E6$)?"[WMILF_T/*/$?QLN%\,Z:V@6
MPA\52-C7[2>V>5/#BV5Q%:7IN8GP!YUW)''!N/W923\P`/GULT:H4_8QY<0_
MXB:O[/E:4KKS;2C?H=-/!I5)<[O37PM/XKJZ^Y;DFL^/M?A\5^)]*/CSPKX2
ML](O+6"QM]:TH7$]U%+913R21RK.FY4D8@Y!^^/2G4QE98BO3^MTL/&E)**G
M"[:LGNGT%"C3]E3E[&=1R3NXRM:SL:ZZQ\0]4\10^'M%\4>'U^S>$M*UZ?4I
M=#,]IJ<M[-)'YULB7`>""1&A8#<V!G'6M%5QM2NJ-+$4URT8U'+DO&3;W2O=
M)JQ/)0A3=25.6LW%1YM59=>]B*X^(OB:"P.GW<-A8>)]&\;^'O#FM&WC:XT^
M\T_5C(\=Y9+.V^'SX$SAB2A&?XL*GC:\8<DE&%>E7ITYV5XN,[V<;[72^0UA
MZ=^9-NG*G*4>C3CT=NQK1:QX^\9:AKDOA+4M%\/:%H>IW.BVTNHZ<^IW6L7]
M@56[ED'F*+2S$C!5*`O@YY(.-%5Q>)G5>&G"A1I2<$Y1YG.4=[_RK\2.2A1C
M!58RG.24FD[**>WJR[XH\3>+=#\)Z/;?9M./Q`UZZBTNPL['=<V(NPS2W%TB
MW`&8([./<^\[4>9025&3=>OB*.'IQY8_7*S4(QCK&_5Z]E\DV*G3I3JRU?L*
M:NV]';HM//\`(SM1^(6HR_#K2/$^EM#;:I-JVD:3JD,T`E%K>'4$L-6MC"Y'
MEMO#E,\JKH:SGC)_4J>(IVC4<X0DFKVES<LU;\O5#C0BJ\J4K\JBY1Z:6O%G
MM%>GM\CD/&-<\6>)=0UGQ%9:#K.A^$]!\'_98-9\0ZU:B],^I7:*ZVL,,DL<
M<%O'O1&D8[BS<?>`KS:N(KRJUHT:L,-1PUE.I-7O)]$M$DNYUPI4X0IN<)5)
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M4U*,]>63=TVNZZ7\CKO!OB/4-<U/QQ;W<L,MKHGB`6.E>5"L3+9-917""5@<
MS.6?.X@'!Q73AJTZL\4I-.-&IRPLK>[RW5^YE5IQIQH\JLY1O+UO;Y'EMGX\
M\;ZQ%X,M;77M$T>YUU/%3WNH:AID,EHO]BZ@\-H@C,\8C9H$V<-\S'/M7!#%
MXJHL-&-:%*555;RE%<ON2LM+JVFGJ=+H48>U;A*2AR62>NJU_$]*^'?BC5=?
M'B'3]8ETR_N_#>J)IQUG1@ZZ;JBR0B820HSN$FB^Y(JN5&5Q[]N#KU*WMH5'
M&4J$N7GA\,M+Z>:ZV.>O2C3]FX)Q4U?EEO&VAZ37:<Y\W>%/!5AK_P`)&T^[
ME9+JPN]1U#3=3ACV7%A=Q01L'B`ER8W13'(F\!U;L54KXN'PL*V7.$G:4)2E
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MTG4[E@EU=6<T5Y$7CD=0_DNNT8`R<<XXF=7+ZK5":Y,1)RY91OR2>[337W,N
MC&&)@O:1:E125T[72V35M+=S6/A)=!G^&N[4);^_O?&=WX@U;4)X5CDU#4=1
MTYVE81)*1;QJNQ%7<^`GJU:?5_8O`>^Y3E6=2<FK<TI1N]+Z+[R55YUB/=Y8
MQIJ,5?9)F+XM\/Q>"?%NK:[X>G-HVI^%=<GBLO+)M].U"\N+2TN+RS"RJ$5G
MD$_E!5'F)P=I`7+$TEA,14JT7R\]*;4;:1DVHMK7SO;N71FZU*,)J_+.*OU:
M2;2?W6+VK?"7P]H_@HZKIUWJT&M:/IUKK%I?/J%W+;KJ=J(;M[D::UP((S+(
MLG"@%?,X8D<W4R^C2POM(2FJM**FI<S:YE9WY;V5_P`"88FI*MRM)PDW%JRV
MVM>U]#C9O'/B/PWXB\0:AI3:6K>(O[&U&\BO+">Y$4R:1;#;`T>H0X3,KG!!
M[<\<\KQE:A6K3I\O[[DE)2BWKR+:TEW-E0ISITXRNO9\R5G;[3\GV/7O',MQ
MKGPE>YNGBCNK_3]`NIWAB80B:2]TZ>3RX6E)5"V0%,C$#')QSZ6*;JY=S.RE
M.--NRTNW%Z+_`()RT$J>*26T7)+Y)HK_`!(\+Z1!X0\3ZE96D%IJ>N_V!_:5
MZD99[C['?68BRF\!<A<MLV[FPS[F&:G&T*<<-7J0BHU*GL^:7>S5O3S[]1X:
MI)UJ<&[QI\W*NUTSRWQ-KFH>&?&_B\V5KH%ZNHW]G,XUG1O[0>$P:?!&JP2?
M;(MBL&)88Y('ISP5ZT\/BL1RQIRYI)^_#FM:*6FJL=%.FIT:5W*/*FO=E;J_
M(6^\6^(=+U[3/$6GR:3!?ZUX/TFQN8VTR5[*%$N[ED-I;KJ"&$*8T`0NX`&/
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MO#&D7,HTAKCPOXHLX;PRW<EGJ$=XD5R#-).&N([ADC9BQ5AL`R>IYL126&^L
M8>FVJ=Z56*=WRR32>K>M^OH;49>U]G4DO>BIP=M+JVFG2QZ+\-/'WB3Q3K5Y
M8ZP=*-M!IK74?V&QGM91,MS!$-SRW\X*;)'^4*#G!SQ@]N!Q=;$5)0J\B48W
M7+%IWNEUD^YSXBA3I03A>[=M6GT]$8?Q+:\\`:E?>(M'>PO++Q<]M%K7A[6-
M.%_ITM[9(L<.H1,+F,HY0J6C*LK,N[/3;ECN;!SE6I<LH8BRG3G'FCS1T4MU
M]Q>'M7BJ<KQ='X91=G9]-C-M/!UL(/AZ-2>RU"'Q#XQU7Q!?V(TN*VTT?;]-
M1#80V0GD2.UC^SH5!+#MM``K..&BE@N=J2K5I5)1Y4HZQ2Y5&[T5BW5=Z_+>
M/LJ:BG>[T>]^^IL_\(9I]MX@\2_#>V?[/X;\4Z:OB&SCA@1+CP_JEO.FUK.8
M-^_M1-"CK#(%V`!%8`L6U^K0C6KX&/NT*\?:15M:<T].5]5=;/;:Y'M9>SIX
MC_EY2?*^TEYKH_,Y_2M1\2_$+5Y/AYX@UFW_`+(TB:)]4N;+3#;W_B"'3I5D
MCM[F1KZ1+19'B0NT:,21G%8TIU\94^I5:B]G3?O.,;2J*&R;YM+VUL7*-/#P
M5>G"TY?"F](W[::V-'QM?:U\-_$MV_AJ^M$MO'4L,\]K>Z>;@:5?QQK8F[LY
M$NXMX9%#>5(FT%0.0*O%3JX&O+V$DHXMIM2C?DDERW3NON9-&,*]->TB[T-$
MT[76]GH7#\/M&@UOX;>&]22/6M.M=%\1S74=];X6^N[DI?/<LBRXBVW,A94R
M^`JC)QDU]3I1JX&A-*I",*C:DOB;]Z]KZ:["5>?)B*D?<;E&UNB6EON/=M+T
MC2]#LX]/T>PM=-LH22EM9PI!$&;[SE4`W.<#+').!D\5ZU.G3HQ4*4%3A'91
05D<4I2D[RDY/NS1JR3__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
